AI PLATFORM
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical
company utilizing artificial intelligence, or AI, approaches to develop
transformative medicines in neuroscience and immuno-oncology.
Innovating Medicine by Leveraging Artificial Intelligence

We are focused on utilizing cutting-edge technology and innovative research to
develop high-value therapeutics aimed
at transforming patients’ lives. BioXcel
Therapeutics employs a unique AI
platform in an effort to reduce therapeutic development costs and potentially
accelerate timelines while aiming to
increase the possibility of success.
Innovating Medicine by Leveraging Artificial Intelligence

We are focused on utilizing cutting-edge technology and innovative research to
develop high-value therapeutics aimed
at transforming patients’ lives. BioXcel
Therapeutics employs a unique AI
platform in an effort to reduce therapeutic development costs and potentially
accelerate timelines while aiming to
increase the possibility of success.
Our approach leverages existing approved drugs and/or clinically evaluated product candidates together with big data and proprietary machine learning algorithms to identify
new therapeutic indices. We believe that this differentiated approach has the potential to
reduce the expense and time associated with drug development in diseases with substantial
unmet medical needs.
Therapeutic Area Focus
Targeting neuroscience disorders and immuno-oncology with significant unmet medical needs and large market opportunities
Drug Re-Innovation
Our proprietary drug development approach aims to leverage existing approved drugs and/or clinically evaluated product candidates
Higher Probability of Success
Developing first-in-class drug candidates while aiming for
a higher probability of clinical and regulatory success
Therapeutic Benefit
Potential to provide clinical benefit to patients in need
Our Differentiated Approach

Our Differentiated Approach
Therapeutic Area Focus
Targeting neuroscience disorders and immuno-oncology with significant unmet medical need and large market opportunity
Drug Re-Innovation
The proprietary drug development approach aims to leverage existing approved drugs and/or clinically evaluated product candidates
Higher Probability of Success
Developing first-in-class drug candidates while aiming for
a higher probability of clinical and regulatory success
Therapeutic Benefit
Potential to provide clinical benefit to patients in need
